- Research works
- 83 ▼ 66% vs 2013–17
- Citations
- 443 5.4 per fractional work
- Top-10% rate
- 16.8% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: CRE Consulting (Poland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 5.9×. Every wedge is a field page.
- Decision Sciences 5.9×
- Immunology and Microbiology 4.9×
- Energy 4.0×
- Economics, Econometrics and Finance 4.0×
- Business, Management and Accounting 2.9×
- Mathematics 2.8×
- Medicine 2.0×
- Environmental Science 1.8×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Engineering 0.6×
- Health Professions 0.5×
- Psychology 0.4×
- Physics and Astronomy 0.4×
- Biochemistry, Genetics and Molecular Biology 0.3×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
Which keywords describe research at CRE Consulting (Poland)?
By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Glycemic Control, Insulin Therapy, Quality of Life, Diabetes, Antiviral Therapy, Liver Disease and Cost-effectiveness Analysis.
- Chronic Hepatitis B
- Revascularization
- Generic Drugs
- Continuous Glucose Monitoring
- Glucose Control
- Atherosclerosis
- Heart Failure
- Ribavirin
- Hepatitis C Virus
- Type 2 Diabetes
- Genetic Variation
- Clinical Guidelines
- Cardiovascular Disease
- Chronic Lymphocytic Leukemia
- Treatment
- Liver Disease
- Cost-effectiveness Analysis
- Diabetes
- Glycemic Control
- Epidemiology
- Quality of Life
- Immune Response
- Insulin Therapy
- Antiviral Therapy
- Health Utility Measures
- Rituximab
- Prognostic Factors
- Genomic Aberrations
- Guidelines
- Risk Factors
- Global Burden
- Complications
- Hepatocellular Carcinoma
- Type 1 Diabetes
- Pharmaceutical Industry
- Cardiovascular Outcomes
- Health Outcomes
- Drug Development Costs
- Hypoglycemia
- Life Expectancy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life6▲ 5.9×7 topics
- Epidemiology6▲ 1.90×22 topics
- Immune Response6▲ 12×5 topics
- Glycemic Control6▲ 51×3 topics
- Insulin Therapy6▲ 64×3 topics
- Diabetes5▲ 12×6 topics
- Antiviral Therapy5▲ 40×2 topics
- Cost-effectiveness Analysis5▲ 78×1 topic
- Health Utility Measures5▲ 78×1 topic
- Liver Disease5▲ 44×2 topics
- Rituximab4▲ 33×2 topics
- Treatment4▲ 3.8×5 topics
- Prognostic Factors4▲ 10×2 topics
- Chronic Lymphocytic Leukemia4▲ 91×1 topic
- Genomic Aberrations4▲ 91×1 topic
- Cardiovascular Disease4▲ 3.9×7 topics
- Guidelines4▲ 9.2×8 topics
- Clinical Guidelines4▲ 13×4 topics
- Risk Factors4▲ 4.1×7 topics
- Genetic Variation3▲ 13×5 topics
- Global Burden3▲ 7.5×4 topics
- Type 2 Diabetes3▲ 21×4 topics
- Complications3▲ 7.4×4 topics
- Hepatitis C Virus3▲ 70×1 topic
- Hepatocellular Carcinoma3▲ 17×2 topics
- Ribavirin3▲ 70×1 topic
- Type 1 Diabetes3▲ 40×2 topics
- Heart Failure3▲ 7.9×5 topics
- Pharmaceutical Industry3▲ 84×2 topics
- Atherosclerosis3▲ 8.9×3 topics
- Cardiovascular Outcomes3▲ 76×1 topic
- Glucose Control3▲ 76×1 topic
- Health Outcomes2▲ 13×3 topics
- Continuous Glucose Monitoring2▲ 65×1 topic
- Drug Development Costs2▲ 117×1 topic
- Generic Drugs2▲ 117×1 topic
- Hypoglycemia2▲ 65×1 topic
- Revascularization2▲ 20×3 topics
- Life Expectancy2▲ 44×2 topics
- Chronic Hepatitis B2▲ 47×1 topic
Which research topics does CRE Consulting (Poland) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Big Data and Business Intelligence, Lymphoma Diagnosis and Treatment and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 2 Big Data and Business Intelligence Management Information Systems 1 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 7 Global Cancer Incidence and Screening Oncology 0 works
- 8 Design Education and Practice Mechanical Engineering 0 works
- 9 Atmospheric aerosols and clouds Global and Planetary Change 0 works
- 10 BIM and Construction Integration Building and Construction 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CRE Consulting (Poland)'s research output changed?
Output in 2018–2022 was 66% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Warsaw
- University of Warsaw
- Polish Academy of Sciences
- Warsaw University of Technology
- Warsaw University of Life Sciences
- Medical University of Warsaw
- Institute of Physics
- Military University of Technology in Warsaw
- Cardinal Stefan Wyszynski University in Warsaw
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.